Invesco’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $448K | Buy |
396,512
+111,305
| +39% | +$126K | ﹤0.01% | 3201 |
|
|
2025
Q1 | $416K | Buy |
285,207
+157,721
| +124% | +$230K | ﹤0.01% | 3213 |
|
|
2024
Q4 | $272K | Buy |
127,486
+8,359
| +7% | +$17.8K | ﹤0.01% | 3429 |
|
|
2024
Q3 | $334K | Sell |
119,127
-1,011
| -0.8% | -$2.83K | ﹤0.01% | 3368 |
|
|
2024
Q2 | $280K | Sell |
120,138
-545
| -0.5% | -$1.27K | ﹤0.01% | 3515 |
|
|
2024
Q1 | $539K | Buy |
120,683
+18,707
| +18% | +$83.6K | ﹤0.01% | 3278 |
|
|
2023
Q4 | $327K | Buy |
101,976
+8,464
| +9% | +$27.2K | ﹤0.01% | 3394 |
|
|
2023
Q3 | $296K | Buy |
93,512
+1,242
| +1% | +$3.94K | ﹤0.01% | 3449 |
|
|
2023
Q2 | $459K | Sell |
92,270
-2,738
| -3% | -$13.6K | ﹤0.01% | 3274 |
|
|
2023
Q1 | $469K | Buy |
95,008
+5,201
| +6% | +$25.7K | ﹤0.01% | 3279 |
|
|
2022
Q4 | $565K | Sell |
89,807
-384
| -0.4% | -$2.42K | ﹤0.01% | 3186 |
|
|
2022
Q3 | $974K | Sell |
90,191
-507,974
| -85% | -$5.49M | ﹤0.01% | 2919 |
|
|
2022
Q2 | $6.82M | Buy |
598,165
+515,612
| +625% | +$5.88M | ﹤0.01% | 2102 |
|
|
2022
Q1 | $751K | Buy |
82,553
+45,352
| +122% | +$413K | ﹤0.01% | 3178 |
|
|
2021
Q4 | $556K | Buy |
37,201
+2,091
| +6% | +$31.3K | ﹤0.01% | 3310 |
|
|
2021
Q3 | $902K | Sell |
35,110
-4,301
| -11% | -$110K | ﹤0.01% | 3126 |
|
|
2021
Q2 | $1.03M | Buy |
39,411
+18,236
| +86% | +$476K | ﹤0.01% | 3090 |
|
|
2021
Q1 | $747K | Buy |
21,175
+848
| +4% | +$29.9K | ﹤0.01% | 3153 |
|
|
2020
Q4 | $513K | Buy |
20,327
+7,896
| +64% | +$199K | ﹤0.01% | 3176 |
|
|
2020
Q3 | $468K | Sell |
12,431
-176
| -1% | -$6.63K | ﹤0.01% | 3129 |
|
|
2020
Q2 | $539K | Sell |
12,607
-1,123
| -8% | -$48K | ﹤0.01% | 3080 |
|
|
2020
Q1 | $267K | Buy |
+13,730
| New | +$267K | ﹤0.01% | 3280 |
|